FIRST TRUST ADVISORS LP - IMMUNITYBIO INC ownership

IMMUNITYBIO INC's ticker is IBRX and the CUSIP is 45256X103. A total of 144 filers reported holding IMMUNITYBIO INC in Q4 2022. The put-call ratio across all filers is 1.25 and the average weighting 0.1%.

Quarter-by-quarter ownership
FIRST TRUST ADVISORS LP ownership history of IMMUNITYBIO INC
ValueSharesWeighting
Q1 2023$283,004
-4.4%
155,497
+166.2%
0.00%
Q4 2022$296,123
-21.0%
58,407
-22.5%
0.00%
Q3 2022$375,000
+66.7%
75,369
+24.6%
0.00%
Q2 2022$225,000
-93.7%
60,472
-75.8%
0.00%
-100.0%
Q2 2021$3,571,000
-51.6%
250,096
-19.6%
0.00%
-55.6%
Q1 2021$7,381,000310,9200.01%
Other shareholders
IMMUNITYBIO INC shareholders Q4 2022
NameSharesValueWeighting ↓
Winning Points Advisors, LLC 236,956$879,0000.97%
HARBOURVEST PARTNERS LLC 335,709$1,249,0000.41%
ALLEN HOLDING INC /NY 687,571$2,558,0000.37%
MERIDIAN INVESTMENT COUNSEL INC. 96,433$359,0000.15%
SHEETS SMITH WEALTH MANAGEMENT 207,926$773,0000.13%
Corton Capital Inc. 29,032$108,0000.10%
Clearwater Capital Advisors, LLC 185,311$689,0000.09%
Delphia (USA) Inc. 31,709$118,0000.08%
Virtus ETF Advisers LLC 34,799$129,0000.05%
GSA CAPITAL PARTNERS LLP 84,884$316,0000.05%
View complete list of IMMUNITYBIO INC shareholders